Versant Venture Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Versant Venture Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000,000	Closed	-$6.1M	–	12
2021 Q3	$6.1M	Hold	1,000,000	–	–	2.53%	9
2021 Q2	$8.23M	Sell	1,000,000 -310,169	-24%	-$2.64M	2.73%	8
2021 Q1	$11.7M	Sell	1,310,169 -2,532,409	-66%	-$29M	2.28%	8
2020 Q4	$44.3M	Hold	3,842,578	–	–	4.6%	5
2020 Q3	$40M	Buy	+3,842,578	New	+$47.1M	7.32%	4

Versant Venture Management's FLXN Position: Q4 2021 in Review

Versant Venture Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 1,000,000 shares — an estimated $6.1M sold.

Versant Venture Management first reported a position in FLXN in Q3 2020 and held it in 5 quarters. The position peaked at $44.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Versant Venture Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Versant Venture Management sold 1,000,000 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $6.1M.
Versant Venture Management first reported a position in Flexion Therapeutics, Inc. in Q3 2020 and held it in 5 quarters.
Versant Venture Management's Flexion Therapeutics, Inc. position peaked at $44.3M in Q4 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Versant Venture Management's 13F filing for Q4 2021, filed 11 Feb 2022.